University of Iowa, Iowa City, IA, USA.
J Oncol Pract. 2013 Jan;9(1):20-6. doi: 10.1200/JOP.2012.000829.
Little has been published on nontreatment of cancer, yet the National Cancer Data Base (NCDB) indicates that 9.2% of patients receive no first course of treatment. Because the NCDB is limited to accredited cancer programs, there is potential for the actual rate to differ. We sought to understand the rate and characteristics of patients with cancer who receive no first course of treatment in a more population-representative data source.
The Iowa Cancer Registry (ICR) strives to capture 100% of newly diagnosed cancer cases among Iowa residents, regardless of where they are diagnosed or treated.
In the ICR from 2004 to 2010, 12.3% of newly diagnosed patients with cancer did not receive a first course of treatment, which is 48% higher than the NCDB data for the state of Iowa (8.3%) during the same time period. Logistic regression indicated that nontreatment was more common in certain cancers (ie, small-cell and non-small-cell lung/bronchial cancers and low-grade non-Hodgkin lymphoma), advanced stages, older patients, those receiving treatment recommendations at nonaccredited cancer programs, and patients who never consulted an oncologist, radiation therapist, or surgeon. Distance to treatment facilities was not related to nontreatment.
The rate of nontreatment varies by cancer type and stage and is higher in patients receiving initial treatment recommendations in nonaccredited cancer programs than in accredited cancer programs. This pattern seems to be correlated with patient characteristics but also may be related to provider and facility characteristics available to people locally that influence both patient and provider decision making.
鲜有关于癌症未治疗的报道,但国家癌症数据库(NCDB)显示,9.2%的患者未接受第一疗程的治疗。由于 NCDB 仅限于认可的癌症项目,实际比率可能存在差异。我们试图在更具代表性的人群数据来源中了解未接受第一疗程治疗的癌症患者的比率和特征。
爱荷华癌症登记处(ICR)努力捕获所有居住在爱荷华州的新诊断癌症患者,无论其在何处诊断或治疗。
在 2004 年至 2010 年期间,ICR 中有 12.3%的新诊断癌症患者未接受第一疗程的治疗,比同期 NCDB 爱荷华州的数据(8.3%)高 48%。逻辑回归表明,在某些癌症(即小细胞和非小细胞肺/支气管癌以及低级别非霍奇金淋巴瘤)、晚期、老年患者、在非认可的癌症项目中接受治疗建议的患者以及从未咨询过肿瘤学家、放射治疗师或外科医生的患者中,未治疗的情况更为常见。治疗设施的距离与未治疗无关。
未治疗的比率因癌症类型和阶段而异,在非认可的癌症项目中接受初始治疗建议的患者中高于认可的癌症项目。这种模式似乎与患者特征相关,但也可能与当地影响患者和提供者决策的提供者和设施特征有关。